Europe · More sources · The Guardian Business
GSK shares dive as weaker vaccine sales and restructuring charges unnerve investors
British pharma company reports declining profits amid concerns over looming patent loss for blockbuster HIV drugBusiness live – latest updatesShares in GSK slid on Wednesday…
Read the full article on The Guardian Business Sign in to saveMarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.theguardian.com)





